NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/02/2025
Voltar para busca
Dado oficial do USPTO
CELLISTIC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CELLISTIC
ST13
US500000097301281Classe
7, 9, 40, 42
Pedido
97301281
Registro
7691770
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
18/02/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
7, 9, 40, 42
Data de depósito
08/03/2022
Data de registro
18/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2025
Última transação
18/02/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
33
Localização do titular
MONT-SAINT-GUIBERT, BE
Examinador
MAROTTA, GABRIELLE CHRISTINA
Unidade examinadora
L30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
CELLISTIC SA
Ncardia B.V.
Representantes
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Classificação técnica
Classes Nice
Classe 7Classe 9Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 7
Bioreactors for use in manufacturing biopharmaceuticalscell therapy pharmaceuticals
Classe 9
Scientific apparatus and instrumentsinstruments for cell characterization in the nature of imagers being image scannersflow cytometersnucleic acid sequencers for scientific purposes; cell culture apparatus for laboratory usecell sorting devicescell culture dishestissue culture flasks; bioreactors for cell culturing for scientific research; bioreactors for laboratory use; bioreactors for cell culturing for scientific research use; bioreactors for cell culturing for scientific research usefor cell therapy pharmaceuticals manufacturing
Classe 40
Custom manufacture of biopharmaceuticals; Treatment of materialspharmaceutical and chemical products and their components used in the manufacture of biopharmaceuticals and cell therapy pharmaceuticals; manufacture of cell therapy pharmaceuticals to the order and/or specification of others
Classe 42
Laboratory research in the field of biopharmaceuticals; laboratory research in the field of biotechnology; biotechnology research and testingtesting of pharmaceuticals; development of new technology for others in the field of biotechnology; scientific research on stem cells; scientific research on the production and differentiation of pluripotent stem cells; research and development in the field of stem cellscell therapy pharmaceuticals and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cellscell and gene therapy and biotechnology; research and development for the pharmaceutical industry; Technological consultancy services in the field of biotechnology; technological consulting services in the pharmaceutical industry; graphic design services; graphic design services for the pharmaceutical industry; industrial analysis of biopharmaceutical products to assure compliance with industry standards and research services in the field of biopharmaceuticals; biopharmaceutical research and development; research and development of new products for others; product development consultation; scientific consultancy services in the fields of biotechnology productspharmaceutical productsmedical products; scientific consultancy services for the pharmaceutical industryin the field of pharmaceutical research
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
18/02/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
30/01/2025
EEXT
SOU TEAS EXTENSION RECEIVED
08/01/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
25/09/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/08/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/07/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/07/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/07/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/05/2024
PUBO
PUBLISHED FOR OPPOSITION
14/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/02/2024
GNRT
NON-FINAL ACTION E-MAILED
05/02/2024
CNRT
NON-FINAL ACTION WRITTEN
05/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/11/2023
GNRT
NON-FINAL ACTION E-MAILED
21/11/2023
CNRT
NON-FINAL ACTION WRITTEN
21/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2023
GNRT
NON-FINAL ACTION E-MAILED
11/08/2023
CNRT
NON-FINAL ACTION WRITTEN
11/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/07/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
19/07/2023
ALIE
ASSIGNED TO LIE
18/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/12/2022
GNRT
NON-FINAL ACTION E-MAILED
23/12/2022
CNRT
NON-FINAL ACTION WRITTEN
23/12/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
21/12/2022
DOCK
ASSIGNED TO EXAMINER
19/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/03/2022
NWAP
NEW APPLICATION ENTERED
11/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELLISTIC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.